| 1 |
33419251 | Axitinib in Ponatinib-Resistant B-Cell Acute Lymphoblastic Leukemia Harboring a T315L Mutation. | 2020 Dec 20 |
1 |
| 2 |
30704478 | Helicobacter pylori-controlled c-Abl localization promotes cell migration and limits apoptosis. | 2019 Jan 31 |
2 |
| 3 |
28578803 | Head and neck cancer cell radiosensitization upon dual targeting of c-Abl and beta1-integrin. | 2017 Sep |
1 |
| 4 |
25944899 | The Tyrosine Kinase c-Abl Promotes Homeodomain-interacting Protein Kinase 2 (HIPK2) Accumulation and Activation in Response to DNA Damage. | 2015 Jul 3 |
1 |
| 5 |
24480037 | Serine and proline-rich ligands enriched via phage-display technology show preferential binding to BCR/ABL expressing cells. | 2014 Mar |
1 |
| 6 |
23318434 | Dual regulation of Myc by Abl. | 2013 Nov 7 |
1 |
| 7 |
19643477 | mTOR inhibitor RAD001 (Everolimus) enhances the effects of imatinib in chronic myeloid leukemia by raising the nuclear expression of c-ABL protein. | 2010 May |
3 |
| 8 |
17318191 | Bcr-Abl stabilizes beta-catenin in chronic myeloid leukemia through its tyrosine phosphorylation. | 2007 Mar 7 |
1 |
| 9 |
17382017 | Emerging strategies for the treatment of mutant Bcr-Abl T315I myeloid leukemia. | 2007 Mar |
1 |
| 10 |
17475908 | High levels of the BCR/ABL oncoprotein are required for the MAPK-hnRNP-E2 dependent suppression of C/EBPalpha-driven myeloid differentiation. | 2007 Aug 1 |
3 |
| 11 |
17804707 | Crystal structure of the T315I Abl mutant in complex with the aurora kinases inhibitor PHA-739358. | 2007 Sep 1 |
1 |
| 12 |
16888623 | MUC1 oncoprotein blocks nuclear targeting of c-Abl in the apoptotic response to DNA damage. | 2006 Aug 23 |
4 |
| 13 |
15632178 | Mitotic phosphorylation rescues Abl from F-actin-mediated inhibition. | 2005 Mar 18 |
1 |
| 14 |
15696159 | JNK phosphorylation of 14-3-3 proteins regulates nuclear targeting of c-Abl in the apoptotic response to DNA damage. | 2005 Mar |
1 |
| 15 |
11840343 | Regulation of p73 by c-Abl through the p38 MAP kinase pathway. | 2002 Jan 31 |
1 |
| 16 |
12077114 | Analysis of the structural basis of specificity of inhibition of the Abl kinase by STI571. | 2002 Aug 30 |
1 |
| 17 |
12149456 | Clinical resistance to the kinase inhibitor STI-571 in chronic myeloid leukemia by mutation of Tyr-253 in the Abl kinase domain P-loop. | 2002 Aug 6 |
1 |
| 18 |
8227078 | Phosphorylation of synthetic peptides containing Tyr-Met-X-Met motifs by nonreceptor tyrosine kinases in vitro. | 1993 Nov 25 |
1 |